BioStem Technologies (OTCMKTS:BSEM - Get Free Report) released its earnings results on Monday. The company reported $0.17 EPS for the quarter, missing analysts' consensus estimates of $1.25 by ($1.08), Zacks reports.
BioStem Technologies Trading Up 1.2%
BSEM traded up $0.19 during trading hours on Monday, hitting $15.30. The company's stock had a trading volume of 84,656 shares, compared to its average volume of 65,869. BioStem Technologies has a fifty-two week low of $6.77 and a fifty-two week high of $28.26. The firm has a market capitalization of $255.56 million, a PE ratio of 22.50 and a beta of -0.10. The company has a 50-day simple moving average of $11.22 and a 200 day simple moving average of $13.99.
About BioStem Technologies
(
Get Free Report)
BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider BioStem Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioStem Technologies wasn't on the list.
While BioStem Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
